Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9613364.
- Also identified by PMC identifier 1717498.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against polio, diphtheria, and tetanus) did not cause relapse of thrombocytopenia.
Medical subject headings
- Hepatitis B Vaccines
- Purpura, Thrombocytopenic, Idiopathic
- Vaccines, Synthetic